News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Centauri Therapeutics awarded £1M grant under new PACE programme to advance imm...

Dec 23rd 2024
Centauri Therapeutics Limited (Centauri), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications has been awarde...
Read More

Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment...

Nov 27th 2024
Monument Therapeutics, a precision neuroscience company, today announced the first participant has been successfully dosed in its Phase I clinical study of MT1988, a novel treatment targetin...
Read More

Apini Secures Major Investment as Part of Slingshot Therapeutics Launch

Nov 21st 2024
Apini, a spinout from The University of Manchester and the first programme launched through newly formed Slingshot Therapeutics Limited (“Slingshot”), is poised to accelerate the develop...
Read More

Monument Therapeutics Secures £1M Investment to Advance Schizophrenia Treatment...

Oct 21st 2024
Monument Therapeutics, a leader in precision neuroscience, has announced a significant £1 million equity investment from the Forster Foundation, a charitable organization.
Read More

Liverpool to lead new national healthcare research Hub for Advanced Long-acting ...

Oct 16th 2024
A new national research hub, led by the University of Liverpool, will position the UK as a world leader in the emerging global field of long-acting therapeutics (LATs).
Read More

BioTryp Therapeutics Raises Pre-Seed Funding to advance its novel biofilm-inhibi...

Sep 20th 2024
Cambridge, UK: BioTryp Therapeutics, an award-winning drug discovery spin-out from the University of Cambridge, has raised £300k in pre-seed funding to advance the development of its novel ...
Read More

Precision neuroscience company Monument Therapeutics announces £1.5m funding to...

Apr 22nd 2024
Monument Therapeutics, a precision neuroscience company, today announced new funding of £1.5 million from a combination of equity investment and non-dilutive grant as part of the Innovate U...
Read More

Major funding extension to advance revolutionary long-acting therapeutic technol...

Apr 22nd 2024
Unitaid has awarded more than £6M of new funding to a University of Liverpool-led project aiming to improve the long-acting therapeutics available to treat or prevent tuberculosis, malaria ...
Read More

Drug Discovery and Advanced Therapeutics Innovation Lab

Feb 15th 2024
The University of Manchester is looking for businesses active in the Drug Discovery and Advanced Therapeutics field to join a sandpit event aimed at fostering academic-industry collaboration...
Read More

Aptamer Group signs two substantial new contracts

Jan 25th 2023
Contracts worth over £500,000 with the potential for downstream milestone and royalty/ licensing payments
Read More

£1.3M to develop new inhaled drug delivery platforms to treat viral and bacteri...

Mar 8th 2022
The University of Liverpool in partnership with the Liverpool School of Tropical Medicine have joined forces on a £1.3million research project to develop new inhaled drug delivery platforms...
Read More

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify ...

Jul 22nd 2021
Aptamer Group Limited, the developer of Optimer™ therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, today annou...
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners